Smith Isabella, Bleibleh Sabri, Hartley Laura J, Rehousek Petr, Hughes Simon, Grainger Melvin, Jones Morgan
North Bristol NHS Foundation Trust, Bristol, UK.
Department of Spinal Surgery, The Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, UK.
J Spine Surg. 2022 Sep;8(3):353-361. doi: 10.21037/jss-22-27.
Total en bloc spondylectomy (TES) is a widely accepted surgical technique for primary spinal bone tumours but is frequently accompanied by substantial peri-operative blood loss. Prior studies have reported estimated blood loss (EBL) can reach up to 3,200 mL. The aim of this study is to estimate the blood loss during TES procedures performed in the last ten years at our tertiary referral centre and compare EBL with actual blood loss (ABL).
We performed a retrospective review of all cases managed surgically with TES referred to our centre between 2005 and 2015. We recorded the oncological characteristics of each tumour and surgical management in terms of resection margins, operative duration and instrumentation. Data relating to peri-operative blood loss was also recorded including an estimation of total blood loss, the use of cell salvage where applicable and transfusion rates.
A total of 21 patients were found to meet our inclusion criteria. There were 11 men and 10 women, with a median age of 40 years. The mean total ABL was 3,310 mL. Total operation time ranged from 6.53 to 19.7 h. Compared to ABL, in 59% of cases EBL had been underestimated by an average of 78% by volume. The EBL of the remaining 41% cases had been overestimated by 43%. This was not statistically significant (P=0.373). Cell salvage was used in 62% patients with a mean blood loss of 2,845 mL (884-4,939 mL) and transfusion of 3.8 units (0-12 units) versus 4,069 mL (297-8,335 mL) and 9.3 units (0-18 units) in those not managed with cell salvage. There was no significant difference in ABL between the cell salvage and non-cell salvage groups.
We report one of the largest case series in TES for primary bone tumours. EBL is not a reliable predictor for ABL. A large blood loss should be anticipated and use of cell salvage is recommended.
整块全脊椎切除术(TES)是治疗原发性脊柱骨肿瘤广泛认可的手术技术,但常常伴有大量围手术期失血。既往研究报道估计失血量(EBL)可达3200毫升。本研究旨在评估过去十年在我们三级转诊中心进行的TES手术中的失血量,并将EBL与实际失血量(ABL)进行比较。
我们对2005年至2015年间转诊至我们中心接受TES手术治疗的所有病例进行回顾性研究。我们记录了每个肿瘤的肿瘤学特征以及手术处理情况,包括切除边缘、手术持续时间和内固定情况。还记录了围手术期失血相关数据,包括总失血量估计、适用时细胞回收的使用情况和输血率。
共发现21例患者符合纳入标准。其中男性11例,女性10例,中位年龄40岁。平均总ABL为3310毫升。总手术时间为6.53至19.7小时。与ABL相比,59%的病例中EBL在量上平均低估了78%。其余41%病例的EBL高估了43%。这无统计学意义(P = 0.373)。62%的患者使用了细胞回收,平均失血量为2845毫升(884 - 4939毫升),输血量为3.8单位(0 - 12单位),而未使用细胞回收的患者失血量为4069毫升(297 - 8335毫升),输血量为9.3单位(0 - 18单位)。细胞回收组与非细胞回收组之间ABL无显著差异。
我们报告了原发性骨肿瘤TES最大病例系列之一。EBL不是ABL的可靠预测指标。应预计到大量失血,建议使用细胞回收。